DEA releases 2019 National Drug Threat Assessment
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • DEA releases 2019 National Drug Threat Assessment

DEA releases 2019 National Drug Threat Assessment

January 30, 2020
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kelly McKay
Phone Number: (571) 324-6204

Annual report outlines strategic review of threats posed by drugs and drug traffickers

SAN DIEGO – DEA Acting Administrator Uttam Dhillon today announced the publication of the 2019 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs.

“This year’s report illustrates a shifting drug landscape in the United States,” said Acting Administrator Dhillon. “We’re pleased that in 2018, drug overdose deaths declined over four percent overall, with even greater decreases – over 13 percent – in overdoses from controlled prescription opioids. Many challenges remain, however, including the spread of fentanyl and methamphetamine across the country. DEA and its partners will continue to work diligently to combat the drug trafficking organizations that bring these deadly substances into our country and endanger the American people.”

“Unlike other cities, San Diego faces unique challenges by being on the U.S.-Mexico border,” said San Diego Special Agent in Charge John W. Callery. “In 2018, the DEA San Diego seized record amounts of methamphetamine and deadly fentanyl. While our battle with the Mexican drug cartels persists, our agents are more committed than ever to stemming the flow of these deadly drugs entering our community and affecting the lives of our friends and families.”

Illicit drugs, and the criminal organizations that traffic them, continue to represent significant threats to public health, law enforcement, and national security in the United States. As the National Drug Threat Assessment describes, the opioid threat continues at epidemic levels, affecting large portions of the United States. Meanwhile, the stimulant threat, including methamphetamine and cocaine, is worsening and becoming more widespread as traffickers continue to sell increasing amounts outside of each drugs’ traditional markets.   

2019 National Drug Threat Assessment findings of note pertaining to San Diego:

  • The Sinaloa Cartel and Jalisco New Generation Cartel are the most dominant Mexican Transnational Criminal Organizations  affecting the San Diego region. Both Sinaloa Cartel and CJNG control the Tijuana/San Diego trafficking corridor.
  • Gang activity in San Diego shows poly-drug gang associates transport and sell anything that will generate a profit. At the retail level, gang members primarily sell methamphetamine, heroin, and marijuana. The trafficking of marijuana and pills, both diverted and counterfeit oxycodone, has increased, due to higher profit margins than methamphetamine and heroin.
     
  • While heroin availability in San Diego is moderate, fentanyl availability is high and increased in San Diego and across the majority of the United States in 2018, highlighting the rapid spread of the drug. Fentanyl remains the primary driver behind the ongoing opioid crisis.  Increases in fentanyl-containing counterfeit pills demonstrates traffickers’ continued efforts to expand the fentanyl user base.
     
  • Methamphetamine availability in San Diego is high. Mexican TCOs continue to be the primary producers and suppliers of low cost, high purity, high potency methamphetamine in the United States. Mexican TCOs regularly produce large quantities of methamphetamine, which has led to a significant supply of methamphetamine in the U.S. market. The majority of Mexican TCOs are involved in methamphetamine trafficking, which has led to increased competition among the different TCO groups, TCOs exploring new markets for methamphetamine, and increasing quantities coming across the Southwest Border. The price of methamphetamine may begin to rise with a market expansion, although currently, prices in established markets remain consistently low.
     
  • Cocaine was less available in the San Diego region than in the previous year.  Cocaine consumption by minors in San Diego used to be infrequent but now has become more mainstreamed and even “normalized.”

The National Drug Threat Assessment provides a yearly assessment of the many drug abuse and drug trafficking challenges local communities face. Highlights in the report include usage and trafficking trends for drugs such as prescription drugs, heroin, methamphetamine, cocaine, marijuana and the hundreds of synthetic drugs. New to this year’s assessment is an expanded section on gangs - including street gangs, prison gangs, and outlaw motorcycle gangs – which now details gang activity geographically by DEA field division.

The assessment factors in data from many sources, including drug seizures, drug purity, laboratory analyses, information on the involvement of organized criminal groups, and survey data provided to DEA by state and local law enforcement agencies across the country.

The National Drug Threat Assessment can be accessed at https://go.usa.gov/xdjnt.

# # #

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

James M. Nunnallee Special Agent in Charge - San Diego
@DEASanDiegoDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster